VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Palonosetron only
Preclinical
Small molecule
Y
Yonsei University
1
Indications
2
Total Trials
0
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Vomiting
1 trial
Comparison of Palonosetron Versus Combination of Palonosetron and Dexamethasone for Preventing Postoperative Vomiting in Patients Receiving Fentanyl by Patient-controlled Analgesia After Minor Orthopedic Surgery
Completed
·
Y
Yonsei University
·
N/A
·
NCT02744508
·
202 enrolled
Dexamethasone
1 trial
Efficacy of IV Palo With IV Dexamethasone vs IV Palo for Prevention of Immediate & Delayed PONV
Completed
·
N
NYU Langone Health
·
Phase 4
·
NCT00952133
·
118 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for Palonosetron only. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Palonosetron only compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Palonosetron only. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Yonsei University company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
Y
Yonsei University
Related News